![Cancer Network](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/005/617/normal/Screenshot_2020-10-13_at_09.14.31.png?1602576896)
The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical Study
Cancer Network,
Kira MacDougall, MD, and co-investigators, research the importance of peripheral biomarkers in patients with advanced non–small…